Wang Shuangshuang, Hu Siwang
Department of Cardiology, The First People's Hospital of Wenling (The Affiliated Wenling Hospital of Wenzhou Medical University), Wenling, China.
The Orthopedic Center, The First People's Hospital of Wenling (The Affiliated Wenling Hospital of Wenzhou Medical University), Wenling, China.
Front Cardiovasc Med. 2022 Jun 1;9:894692. doi: 10.3389/fcvm.2022.894692. eCollection 2022.
Vascular calcification (VC) is a common pathological change in many chronic diseases, such as diabetes and chronic kidney disease. It is mainly deposited in the intima and media of vessels in the form of hydroxyapatite. Recently, a lot of research has been performed to show that VC is associated with various cellular stresses, such as hyperphosphate, hyperglycemia and oxidative stress. Unfortunately, our understanding of the pathogenesis of calcification is far from comprehensive. Sirtuins belong to a family of class III highly conserved deacetylases that are involved in the regulation of biological and cellular processes including mitochondrial biogenesis, metabolism, oxidative stress, inflammatory response, DNA repair, etc. Numerous studies have shown that sirtuins might play protective roles in VC, and restoring the activity of sirtuins may be a potentially effective treatment for VC. However, the exact mechanism of their vascular protection remains unclear. Here, we reviewed the roles of sirtuins in the osteogenic transformation of vascular smooth muscle cells and the development of VC. We also elucidated the applications of sirtuins agonists for the treatment of VC.
血管钙化(VC)是许多慢性疾病(如糖尿病和慢性肾脏病)中常见的病理变化。它主要以羟基磷灰石的形式沉积在血管内膜和中膜。最近,大量研究表明VC与各种细胞应激有关,如高磷血症、高血糖和氧化应激。遗憾的是,我们对钙化发病机制的理解还远不全面。沉默调节蛋白属于III类高度保守的去乙酰化酶家族,参与包括线粒体生物发生、代谢、氧化应激、炎症反应、DNA修复等在内的生物和细胞过程的调控。大量研究表明,沉默调节蛋白可能在VC中发挥保护作用,恢复沉默调节蛋白的活性可能是治疗VC的一种潜在有效方法。然而,它们血管保护的确切机制仍不清楚。在此,我们综述了沉默调节蛋白在血管平滑肌细胞成骨转化和VC发生发展中的作用。我们还阐明了沉默调节蛋白激动剂在治疗VC中的应用。